Rebamipide mofetil

N/A

Report date: 2024/07/23 14:33:14
NME

Base Information

Drug NameRebamipide mofetil
Drug Alias NameSA-001（Samjin）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes inhibitorsMucin stimulantsProstanoid receptor agonists
TargetsEnzymesMucinProstanoid receptor
Therapy Area/IndicationsDry Eye SyndromesSjogren's Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSamjin
China Registration ClassN/A

Develop Information

Active CompaniesSamjin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSjogren's Syndrome
Inactive IndicationsDry Eye Syndromes

Other Information

ATC CodeN/A
Related LinksN/A